US Patent

US10174074 — Salts and polymorphs of SCY-078

Composition of Matter · Assigned to Scynexis Inc · Expires 2035-01-19 · 9y remaining

Vulnerability score 4/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects novel salts and polymorph forms of SCY-078, a glucan synthase inhibitor with antimicrobial activity.

USPTO Abstract

SCY-078 is a glucan synthase inhibitor with antimicrobial activity. Novel salts and polymorph forms of SCY-078 are disclosed herein. The disclosure also relates to pharmaceutical compositions, methods of use, and methods of preparing the novel salts and polymorphs of SCY-078.

Drugs covered by this patent

Patent Metadata

Patent number
US10174074
Jurisdiction
US
Classification
Composition of Matter
Expires
2035-01-19
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Scynexis Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.